Vedula, R. S., Cheng, M. P., Ronayne, C. E., Farmakiotis, D., Ho, V. T., Koo, S., . . . Bold, T. D. (2020). Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease. Blood Adv.
Chicago Style CitationVedula, Rahul S., Matthew P. Cheng, Christine E. Ronayne, Dimitrios Farmakiotis, Vincent T. Ho, Sophia Koo, Francisco M. Marty, R. Coleman Lindsley, i Tyler D. Bold. "Somatic GATA2 Mutations Define a Subgroup of Myeloid Malignancy Patients At High Risk for Invasive Fungal Disease." Blood Adv 2020.
Cita MLAVedula, Rahul S., et al. "Somatic GATA2 Mutations Define a Subgroup of Myeloid Malignancy Patients At High Risk for Invasive Fungal Disease." Blood Adv 2020.
Atenció: Aquestes cites poden no estar 100% correctes.